Why did I stop? Barriers and facilitators to uptake and adherence to ART in option B+ HIV care in Lilongwe, Malawi

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Kim, Maria H ^a,b   Zhou, Amy ^c   Mazenga, Alick ^b   Ahmed, Saeed ^a,b   Markham, Christine ^d   Zomba, Gerald ^e   Simon, Katie ^b   Kazembe, Peter N ^b   Abrams, Elaine J ^f  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b Abbott Fund Children's Clinical Centre of Excellence   (Malawi)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^e MINISTRY OF HEALTH   (Malawi)

^f Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; ANTIRETROVIRAL THERAPY; ARTICLE; ATTITUDE TO ILLNESS; DRUG THERAPY; DRUG USE; DRUG WITHDRAWAL; FEMALE; HEALTH AUXILIARY; HEALTH PERSONNEL ATTITUDE; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALAWI; MEDICAL DECISION MAKING; MEDICATION COMPLIANCE; PARTNER SUPPORT; PATIENT ATTITUDE; PATIENT CARE; PREGNANT WOMAN; PUERPERIUM; RELIGION; SOCIAL SUPPORT; TREATMENT REFUSAL; VIRUS TRANSMISSION; YOUNG ADULT; CLINICAL TRIAL; FOLLOW UP; HIV INFECTIONS; MULTICENTER STUDY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PSYCHOLOGY;

ANTIRETROVIRUS AGENT;

ADULT; ANTI-RETROVIRAL AGENTS; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALAWI; MEDICATION ADHERENCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84960540299     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0149527     Document Type: Article

References (37)

1. Clouse K, Schwartz S, Van Rie A, Bassett J, Yende N, Pettifor A. "What They Wanted Was to Give Birth; Nothing Else": Barriers to Retention in Option B+ HIV Care Among Postpartum Women in South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2014 Jan 16; 67:e12-8. doi: 10.1097/QAI.0000000000000263 PMID: 24977376
2. Schouten EJ, Jahn A, Midiani D, Makombe SD, Mnthambala A, Chirwa Z, et al. Prevention of motherto-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet. Elsevier; 2011; 378(9787):282-4. doi: 10.1016/S0140-6736(10)62303-3 PMID: 21763940
3. Tweya H, Gugsa S, Hosseinipour M, Speight C, Ng'ambi W, Bokosi M, et al. Understanding factors, outcomes and reasons for loss to follow-up among women in Option B+ PMTCT programme in Lilongwe, Malawi. Tropical Medicine & International Health. 2014 Aug 4; 19(11):1360-6.
4. WHO. WHO PMTCT Update. Geneva Switzerland: World Health Organization; 2012 Jun.
5. Office LDH. 2014 Mid year population projection. Malawi; 2014 Jun.
6. Ahmed S, Kim MH, Abrams EJ. Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: a review of the evidence for the Option B+ approach. Current opinion in HIV and AIDS. LWW; 2013; 8(5):474-89. doi: 10.1097/COH.0b013e328363a8f2 PMID: 23925003
7. Health MO. Malawi HIV Program Data 2014 Quarter 4. Malawi Ministry of Health; 2014 Jun.
8. Centers for Disease Control and Prevention (CDC). Impact of an innovative approach to prevent mother-to-child transmission of HIV-Malawi, July 2011-September 2012. MMWR Morbidity and mortality weekly report. 2013; 62(8):148. PMID: 23446514
9. Kieffer MP, Mattingly M, Giphart A, van de Ven R, Chouraya C, Walakira M, et al. Lessons learned from early implementation of option B+: the Elizabeth Glaser Pediatric AIDS Foundation experience in 11 African countries. Journal of acquired immune deficiency syndromes (1999). Wolters Kluwer Health; 2014; 67(Suppl 4):S188.
10. Kim MH, Ahmed S, Hosseinipour MC, Giordano TP, Chiao EY, Yu X, et al. Implementation and Operational Research: The Impact of Option B+ on the Antenatal PMTCT Cascade in Lilongwe, Malawi. JAIDS Journal of Acquired Immune Deficiency Syndromes. LWW; 2015; 68(5):e77-e83. doi: 10.1097/QAI.0000000000000517 PMID: 25585302
11. Kim MH, Ahmed S, Preidis GA, Abrams EJ, Hosseinipour MC, Giordano TP, et al. Low Rates of Mother-to-Child HIV Transmission in a Routine Programmatic Setting in Lilongwe, Malawi. Jhaveri R, editor. PLoS One. 2013 May 31; 8(5):e64979. doi: 10.1371/journal.pone.0064979 PMID: 23741437
12. Kim MH, Ahmed S, Buck WC, Preidis GA, Hosseinipour MC, Bhalakia A, et al. The Tingathe programme: a pilot intervention using community health workers to create a continuum of care in the prevention of mother to child transmission of HIV (PMTCT) cascade of services in Malawi. Journal of the International AIDS Society. The International AIDS Society; 2012; 15(4 (Suppl 2)).
13. Patton MQ. Qualitative evaluation and research methods. SAGE Publications, inc; 1990.
14. Pope C, Mays N. Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. BMJ: British Medical Journal. 1995 Jun 26; 311:42-5. PMID: 7613329
15. MacPherson P, MacPherson EE, Mwale D, Squire SB, Makombe SD, Corbett EL, et al. Barriers and facilitators to linkage to ART in primary care: a qualitative study of patients and providers in Blantyre, Malawi. Journal of the International AIDS Society. 2012 Dec 31; 15(2).
16. Tenthani L, Haas AD, Tweya H, Jahn A, van Oosterhout JJ, Chimbwandira F, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ("Option B+") in Malawi. AIDS. 2014 Feb; 28(4):589-98. doi: 10.1097/QAD.0000000000000143 PMID: 24468999
17. Mugavero MJ, Norton WE, Saag MS. Health care system and policy factors influencing engagement in HIV medical care: piecing together the fragments of a fractured health care delivery system. Clinical Infectious Diseases. Oxford University Press; 2011; 52(suppl 2):S238-46. doi: 10.1093/cid/ciq048 PMID: 21342913
18. Gourlay A, Birdthistle I, Mburu G, Iorpenda K, Wringle A. Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review. Journal of the International AIDS Society. 2013 Jul 19; 16:1-21.
19. Hodgson I, Plummer ML, Konopka SN, Colvin CJ, Jonas E, Albertini J, et al. A Systematic Review of Individual and Contextual Factors Affecting ART Initiation, Adherence, and Retention for HIV-Infected Pregnant and Postpartum Women. Newell M-L, editor. PLoS One. 2014 Nov 5; 9(11):e111421. doi: 10.1371/journal.pone.0111421 PMID: 25372479
20. Chinkonde JR, Sundby J, Martinson F. The prevention of mother-to-child HIV transmission programme in Lilongwe, Malawi: why do so many women drop out. Reproductive health matters. 2009 Jul 7; 17:143-51. doi: 10.1016/S0968-8080(09)33440-0 PMID: 19523591
21. Ngarina M, Tarimo EAM, Naburi H, Kilewo C, Mwanyika-Sando M, Chalamilla G, et al. Women's Preferences Regarding Infant or Maternal Antiretroviral Prophylaxis for Prevention of Mother-To-Child Transmission of HIV during Breastfeeding and Their Views on Option B. PLoS One. 1st ed. 2014 Jan 6; 9:1-11.
22. Laher F, Cescon A, Lazarus E, Kaida A, Makongoza M, Hogg RS, et al. Conversations with mothers: exploring reasons for prevention of mother-to-child transmission (PMTCT) failures in the era of programmatic scale-up in Soweto, South Africa. AIDS Behav. Springer; 2012; 16(1):91-8. doi: 10.1007/s10461-010-9875-9 PMID: 21197599
23. Duff P, Kipp W, Wild TC, Rubaale T, Okech-Ojony J. Barriers to accessing highly active antiretroviral therapy by HIV-positive women attending an antenatal clinic in a regional hospital in western Uganda. Journal of the International AIDS Society. BioMed Central Ltd; 2010; 13(1):37.
24. Kebaabetswe PM. Barriers to participation in the prevention of mother-to-child HIV transmission program in Gaborone, Botswana a qualitative approach. AIDS Care. Taylor & Francis; 2007; 19(3):355-60. PMID: 17453569
25. Sprague C, Chersich MF, Black V. Health system weaknesses constrain access to PMTCT and maternal HIV services in South Africa: a qualitative enquiry. AIDS Res Ther. 2011; 8(10).
26. Bwirire LD, Fitzgerald M, Zachariah R, Chikafa V, Massaquoi M, Moens M, et al. Reasons for loss to follow-up among mothers registered in a prevention-of-mother-to-child transmission program in rural Malawi. Transactions of the Royal Society of Tropical Medicine and Hygiene. Elsevier; 2008; 102 (12):1195-200. doi: 10.1016/j.trstmh.2008.04.002 PMID: 18485431
27. Bajunirwe FA, Muzoora M. Barriers to the implementation of programs for the prevention of mother-tochild transmission of HIV: a cross-sectional survey in rural and urban Uganda. AIDS Res Ther. 2005; 2 (10):1-7.
28. Morfaw F, Mbuagbaw L, Thabane L, Rodrigues C, Wunderlich A-P, Nana P, et al. Male involvement in prevention programs of mother to child transmission of HIV: a systematic review to identify barriers and facilitators. Syst Rev. 2013; 2(5).
29. Guest G, MacQueen KM, Namey EE. Applied thematic analysis. Sage; 2011.
30. Creswell JW. Research design: Qualitative, quantitative, and mixed methods approaches. Sage publications; 2013.
31. Haas DW, Ribaudo HJ, Kim RB, Tierney C, Wilkinson GR, Gulick RM, et al. Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study. AIDS. LWW; 2004; 18(18):2391-400. PMID: 15622315
32. Dickinson L, Amin J, Else L, Boffito M, Egan D, Owen A, et al. Pharmacokinetic and Pharmacodynamic Comparison of Once Daily Efavirenz (400 mg vs. 600 mg) in Treatment Naïve HIV Infected Patients: Results of the ENCORE1 Study. Clinical Pharmacology & Therapeutics. Wiley Online Library; 2015; 98 (4):406-16.
33. Sinxadi PZ, Leger PD, McIlleron HM, Smith PJ, Dave JA, Levitt NS, et al. Pharmacogenetics of plasma efavirenz exposure in HIV infected adults and children in South Africa. British journal of clinical pharmacology. Wiley Online Library; 2015.
34. Dhoro M, Zvada S, Ngara B, Nhachi C, Kadzirange G, Chonzi P, et al. CYP2B6∗ 6, CYP2B6∗ 18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe. BMC Pharmacology and Toxicology. BioMed Central Ltd; 2015; 16(1):4.
35. Higgins JA, Hoffman S, Dworkin SL. Rethinking Gender, Heterosexual Men, and Women's Vulnerability to HIV/AIDS. American Journal of Public Health. 2010 Mar; 100(3):435-45. doi: 10.2105/AJPH.2009. 159723 PMID: 20075321
36. Dunkle K, Jewkes RK, Brown HC, Gray GE, McIntry JA, Harlow SD. Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa. Lancet. 2004 Feb 10; 363:1415-21. PMID: 15121402
37. Fox MP, Mazimba A, Seidenberg P, Crooks D, Sikateyo B, Rosen S. Barriers to initiation of antiretroviral treatment inrural and urban areas of Zambia: a cross-sectionalstudy of cost, stigma, and perceptions about ART. 2010 Mar 25;:1-11.